A Study of Inherited Retinal Diseases
Part of Brain & nervous system, Eyes & vision clinical trials.
This study is looking at how inherited retinal diseases affect color vision over time. It may help researchers understand these conditions better and is a good fit for people with a known diagnosis who can describe what they see.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to describe colors or see color test stimuli when asked.
- You need a confirmed diagnosis of an inherited retinal disease (like retinitis pigmentosa).
- You cannot have vision loss from other causes, such as optic nerve damage or brain problems.
- You cannot have a condition that makes it hard to follow instructions or communicate clearly.
- You cannot have had recent retinal surgery or treatments that could temporarily affect your retina.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.
This trial studies a light-guided eye treatment in people with generalized inherited retinal disease (a genetic cause of vision loss). It aims to see whether the approach works safely and can improve function for people whose vision is already significantly reduced.
This study is a registry, meaning it collects information about people with inherited retinal (retina) diseases. It may help researchers learn how these conditions progress and connect you with future studies or treatments.
This study tests a new type of eye imaging to better detect and diagnose early-onset retinal dystrophies in children up to 8 years old. It may help find these conditions sooner and guide treatment.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
Hear when a new Retinal Dystrophies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.